Literature DB >> 12064199

[Cleft lip, maxilla and palate treatment by Dr. Talmant's team in Nantes].

J C Talmant, J P Lumineau, G Rousteau.   

Abstract

Over the last 30 years, our private cleft lip and palate team has developed an increasing activity based on the Victor Veau's concept: "All the structures are present and only deformed". Our goal is to achieve an anatomical and fully functional repair in every fields with the first operation. A few recent refinements have improved our primary procedures: intravelar veloplasty; simultaneous lengthening of the columella and primary lip repair in bilateral clefts; nasal retainer for the 3 or 4 first postoperative months allowing the establishment of a nasal breathing mode at once. Our timing has been the same over the last 21 years if we except that we currently perform the gingivoperiosteoplasty between 4 and 5 years of age so that the width and the relationships of the maxillary arch are normal at the time of the mixed dentition. The timing is the same in uni and bilateral clefts. No preoperative orthopedics. At 6 months of age, nasolabial repair and closure of the soft palate with intravelar veloplasty. At 18 months of age, anatomical closure of the residual cleft of the bony palate in two planes without vomer flap or denuded bone. Between 4 and 5 years of age, after a short orthopedic treatment, closure of the alveolar cleft by a gingivoperiosteoplasty with iliac bone graft. From 6 years of age we start the orthodontic treatment. The current evolution allows to think that only few late corrections will be necessary.

Entities:  

Mesh:

Year:  2002        PMID: 12064199     DOI: 10.1016/s0294-1260(02)00095-x

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  1 in total

1.  The maxillary lateral incisor in the rehabilitation of cleft lip and palate.

Authors:  Guida Paola Genovez Tereza; Marcos Antônio Corrêa Dos Santos; Vivian Patricia Saldias Vargas Winckler; Ana Lúcia Pompeia Fraga de Almeida; Gisele da Silva Dalben
Journal:  J Appl Oral Sci       Date:  2018-05-07       Impact factor: 2.698

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.